These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 20455005)

  • 1. Improved docking, screening and selectivity prediction for small molecule nuclear receptor modulators using conformational ensembles.
    Park SJ; Kufareva I; Abagyan R
    J Comput Aided Mol Des; 2010 May; 24(5):459-71. PubMed ID: 20455005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel inhibitor discovery through virtual screening against multiple protein conformations generated via ligand-directed modeling: a maternal embryonic leucine zipper kinase example.
    Mahasenan KV; Li C
    J Chem Inf Model; 2012 May; 52(5):1345-55. PubMed ID: 22540736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward fully automated high performance computing drug discovery: a massively parallel virtual screening pipeline for docking and molecular mechanics/generalized Born surface area rescoring to improve enrichment.
    Zhang X; Wong SE; Lightstone FC
    J Chem Inf Model; 2014 Jan; 54(1):324-37. PubMed ID: 24358939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational discovery of novel nuclear hormone receptor antagonists.
    Schapira M; Raaka BM; Samuels HH; Abagyan R
    Proc Natl Acad Sci U S A; 2000 Feb; 97(3):1008-13. PubMed ID: 10655475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-Based Virtual Screening.
    Li Q; Shah S
    Methods Mol Biol; 2017; 1558():111-124. PubMed ID: 28150235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Function-specific virtual screening for GPCR ligands using a combined scoring method.
    Kooistra AJ; Vischer HF; McNaught-Flores D; Leurs R; de Esch IJ; de Graaf C
    Sci Rep; 2016 Jun; 6():28288. PubMed ID: 27339552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand-induced shifts in conformational ensembles that describe transcriptional activation.
    Khan SH; Braet SM; Koehler SJ; Elacqua E; Anand GS; Okafor CD
    Elife; 2022 Oct; 11():. PubMed ID: 36222302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using physics-based pose predictions and free energy perturbation calculations to predict binding poses and relative binding affinities for FXR ligands in the D3R Grand Challenge 2.
    Athanasiou C; Vasilakaki S; Dellis D; Cournia Z
    J Comput Aided Mol Des; 2018 Jan; 32(1):21-44. PubMed ID: 29119352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recipes for the selection of experimental protein conformations for virtual screening.
    Rueda M; Bottegoni G; Abagyan R
    J Chem Inf Model; 2010 Jan; 50(1):186-93. PubMed ID: 20000587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand Pathways in Nuclear Receptors.
    Fischer A; Smieško M
    J Chem Inf Model; 2019 Jul; 59(7):3100-3109. PubMed ID: 31246455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flexi-pharma: a molecule-ranking strategy for virtual screening using pharmacophores from ligand-free conformational ensembles.
    Lans I; Palacio-Rodríguez K; Cavasotto CN; Cossio P
    J Comput Aided Mol Des; 2020 Oct; 34(10):1063-1077. PubMed ID: 32656619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Docking of small molecules to farnesoid X receptors using AutoDock Vina with the Convex-PL potential: lessons learned from D3R Grand Challenge 2.
    Kadukova M; Grudinin S
    J Comput Aided Mol Des; 2018 Jan; 32(1):151-162. PubMed ID: 28913782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding pose and affinity prediction in the 2016 D3R Grand Challenge 2 using the Wilma-SIE method.
    Hogues H; Sulea T; Gaudreault F; Corbeil CR; Purisima EO
    J Comput Aided Mol Des; 2018 Jan; 32(1):143-150. PubMed ID: 28983727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-biased ensemble receptor docking (LigBEnD): a hybrid ligand/receptor structure-based approach.
    Lam PC; Abagyan R; Totrov M
    J Comput Aided Mol Des; 2018 Jan; 32(1):187-198. PubMed ID: 28887659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virtual screening of potentially endocrine-disrupting chemicals against nuclear receptors and its application to identify PPARγ-bound fatty acids.
    Jaladanki CK; He Y; Zhao LN; Maurer-Stroh S; Loo LH; Song H; Fan H
    Arch Toxicol; 2021 Jan; 95(1):355-374. PubMed ID: 32909075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of HADDOCK and a simple contact-based protein-ligand binding affinity predictor in the D3R Grand Challenge 2.
    Kurkcuoglu Z; Koukos PI; Citro N; Trellet ME; Rodrigues JPGLM; Moreira IS; Roel-Touris J; Melquiond ASJ; Geng C; Schaarschmidt J; Xue LC; Vangone A; Bonvin AMJJ
    J Comput Aided Mol Des; 2018 Jan; 32(1):175-185. PubMed ID: 28831657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational adaptation of nuclear receptor ligand binding domains to agonists: potential for novel approaches to ligand design.
    Togashi M; Borngraeber S; Sandler B; Fletterick RJ; Webb P; Baxter JD
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):127-37. PubMed ID: 15860255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-canonical modulators of nuclear receptors.
    Tice CM; Zheng YJ
    Bioorg Med Chem Lett; 2016 Sep; 26(17):4157-64. PubMed ID: 27503683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knowledge-Based Methods To Train and Optimize Virtual Screening Ensembles.
    Swift RV; Jusoh SA; Offutt TL; Li ES; Amaro RE
    J Chem Inf Model; 2016 May; 56(5):830-42. PubMed ID: 27097522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the conformational space of a receptor for drug design: An ERα case study.
    Schneider M; Pons JL; Labesse G
    J Mol Graph Model; 2021 Nov; 108():107974. PubMed ID: 34274728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.